Table 3

Multivariable disease-free survival and overall survival analysis of total population (n=365)

Disease-free survivalOverall survival
HR95% CIP valueHR95% CIP value
Age (years)
 ≤60
 >60
1.00
0.98
Ref
(0.78 to 1.23)
0.8521.00
1.10
Ref
(0.84 to 1.45)
0.489
FIGO stage
 IIIC
 IV
1.00
1.25
Ref
(0.96 to 1.64)
0.1001.00
1.15
Ref
(0.82 to 1.62)
0.413
Cycles of NACT
 3–4
 6
1.00
1.09
Ref
(0.85 to 1.38)
0.4981.00
1.24
Ref
(0.93 to 1.65)
0.145
PCI
 ≤10
 >10
1.00
1.25
Ref
(0.96 to 1.64)
0.0981.00
1.10
Ref
(0.80 to 1.51)
0.542
Aletti score
 <8
 ≥8
1.00
1.18
Ref
(0.91 to 1.54)
0.2091.00
1.20
Ref
(0.88 to 1.64)
0.248
CC-score
 CC-0
 CC-1
1.00
1.16
Ref
(0.84 to 1.61)
0.3621.00
1.07
Ref
(0.73 to 1.58)
0.726
CRS
 CRS 1–2
 CRS 3
1.00
0.53
Ref
(0.39 to 0.71)
<0.0011.00
0.42
Ref
(0.28 to 0.63)
<0.001
  • CC, complete cytoreduction; CRS, chemotherapy response score; FIGO, International Federation of Gynecology and Obstetrics; NACT, neoadjuvant chemotherapy; PCI, peritoneal cancer index; Ref, reference.